HMOs Explained: Why They Are Good For The Gut
Mieke Van Den Driessche will take a closer look at an underlying genetic polymorphism which may help to explain why some people don’t respond to targeted interventions, and will introduce new ingredient 2’-Fucosyllactose.
NB: This webinar is only available for Health Professionals.
Want to read more?
Log in or create a Health Professional or Student Health Professional to access the full article
